Experimental Type 1 Diabetes Drug Shields Pancreas Cells from the Usual Crippling Immune System Attack – Good News Network

1. Experimental Type 1 Diabetes Drug Shields Pancreas Cells from the Usual Crippling Immune System Attack Good News Network
2. Experimental antibody drug prevents and even reverses diabetes onset New Atlas
3. Immune-Targeting Drug Improves Insulin Production and Alters Autoimmune Response but Does Not Delay Type 1 Diabetes – NIDDK National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
4. Another Monoclonal Antibody Delays Diabetes in Mouse Study Managed Healthcare Executive
5. Scientists develop experimental type 1 diabetes drug which shields insulin-making cells from immune system attack Diabetes.co.uk

Read original article here